St Jude CE-marks new cardiac technology:
This article was originally published in Clinica
St Jude Medical has CE-marked its dynamic arterial overdrive technology for suppressing atrial fibrillation. It promotes continuous atrial-based stimulation, constantly monitoring atrial activity and adjusting the pacing rate when intrinsic activity is detected. The technology is currently incorporated in the company's Pacesetter Trilogy DR+ device and clinical trials in the US and Canada are ongoing.